Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Amarin
Company Monitoring Page for Amarin
latest headlines for company on cafepharma
The 9 Biotechs With The Highest Growth Expectations
Seeking Alpha
Sat, 02/4/12 - 03:29 pm
Tags:
Theratechnologies
,
SeraCare Life Sciences
,
Gentium
,
Curis
,
BioDelivery Sciences
,
Amarin
,
Affymetrix
,
Affymax
,
Vertex Pharmaceuticals
6 Biotech Plays With High Risk/Reward Potential
Seeking Alpha
Sun, 01/22/12 - 12:20 pm
Tags:
Vertex Pharmaceuticals
,
Chelsea Therapeutics
,
ONYX Pharmaceuticals
,
Amarin
,
Ariad Pharmaceuticals
,
Cell Therapeutics
Amarin CEO Seeks Redemption And Investors at JP Morgan Conference
TheStreet.com
Tue, 01/10/12 - 09:44 am
Tags:
Amarin
,
JPMorgan
,
Pharma CEOs
,
Joe Zakrzewski
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Tags:
Celgene
,
Vivus
,
Dendreon
,
Gilead
,
Incyte
,
YM BioSciences
,
ONYX Pharmaceuticals
,
Seattle Genetics
,
Vertex
,
Amarin
,
Biomarin
,
Biogen Idec
,
Regeneron
,
Merck KGaA
,
Human Genome Sciences
,
Clovis Oncology
,
Roche
,
Ariad
,
Immunogen
,
Medivation
,
Geron
,
InterMune
,
Indenix
,
Amag Pharmaceuticals
,
Mesoblast
,
Arena
,
MannKind
,
Keryx
,
Spectrum Pharmaceuticals
Biotech Stock Mailbag: Most Important Events for 2012
TheStreet.com
Fri, 12/23/11 - 08:56 am
Tags:
Oncothyreon
,
Keryx
,
Vical
,
Aeterna Zentaris
,
Eli Lilly
,
JNJ
,
Elan
,
Celgene
,
Pfizer
,
Gilead
,
Pharmasset
,
Threshold Pharmaceuticals
,
Celldex
,
Amgen
,
BioVex
,
Aveo Pharmaceutical
,
Amylin
,
Alkermes
,
Vertex
,
Cell Therapeutics
,
Amarin
,
ONYX Pharmaceuticals
,
Vivus
5 High Risk/Reward Biotechs For 2012
Seeking Alpha
Mon, 12/5/11 - 06:13 pm
Tags:
ONYX Pharmaceuticals
,
Vertex Pharmaceuticals
,
Amarin
,
Chelsea Therapeutics
,
Cell Therapeutics
Every Biotech Is for Sale
Motley Fool
Wed, 11/30/11 - 10:45 am
Tags:
ONYX Pharmaceuticals
,
Achillion
,
BioSante
,
Indenix
,
Inhibitex
,
GSK
,
Bristol-Myers Squibb
,
Amarin
,
Exelixis
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Tags:
Amarin
,
AMR101
,
Ironwood
,
linaclotide
,
Merck
,
Ariad
,
ridaforolimus
,
Vivus
,
Qnexa
,
Avanafil
,
Amgen
,
Xgeva
,
Cell Therapeutics
,
pixantrone
,
Kalydeco
,
Vertex
,
ONYX Pharmaceuticals
,
Carfilzomib
,
Pfizer
,
Bristol-Myers Squibb
,
Eliquis
,
Chelsea Therapeutics
,
Northera
,
Levadex
,
MAP Pharmaceuticals
,
Roche
,
Curis
,
vismodegib
,
Biogen Idec
,
Elan
,
Tysabri
,
Amylin
,
Bydureon
,
Dapagliflozin
,
Uplypso
,
Protalix BioTherapeutics
,
Teva Pharmaceuticals
,
BioSante
,
Bio-T-Gel
,
Corlux
,
Corcept Therapeutics
,
Discovery Labs
,
Surfaxin
7 Black Friday Biotech Bargains
Motley Fool
Sat, 11/26/11 - 10:50 am
Tags:
Dendreon
,
Human Genome Sciences
,
GSK
,
Avanir
,
Exelixis
,
MannKind
,
Amarin
,
Vertex Pharmaceuticals
Amarin Omega-3 Medication
Investor's Business Daily
Sat, 11/26/11 - 10:46 am
Tags:
Amarin
,
AMR101
,
omega-3 fatty acid
Amarin Stabilizes Ahead Of FDA Decision
Seeking Alpha
Wed, 11/16/11 - 09:49 am
Tags:
Amarin
,
FDA
,
AMR101
Amarin CEO Refuses to Discuss Drug Patent Issues Killing His Stock Price
TheStreet.com
Wed, 11/9/11 - 09:13 am
Tags:
Amarin
,
Joe Zakrzewski
,
patents
,
AMR101
8 Speculative Biotech Buys Based On Last Quarter's Biggest Movers
Seeking Alpha
Mon, 10/3/11 - 12:37 pm
Tags:
Achillion
,
Aeterna Zentaris
,
Antigenics
,
Ariad
,
Amylin
,
Amarin
,
BioDelivery Sciences
,
Cyclacel
,
Geron
,
Dendreon
,
PharmAthene
,
Zalicus
,
Human Genome Sciences
,
Keryx
,
Peregrine Pharmaceuticals
,
SIGA technologies
,
YM BioSciences
7 Possible Biotech Takeover Targets
Seeking Alpha
Sun, 09/18/11 - 12:02 pm
Tags:
Human Genome Sciences
,
Vertex Pharmaceuticals
,
Lexicon Pharmaceuticals
,
Amarin
,
Exelixis
,
Dendreon
,
Acorda Therapeutics
2 Healthcare Companies Expecting September Catalysts
Seeking Alpha
Thu, 09/1/11 - 08:03 am
Tags:
Amarin
,
AMR101
,
Iluvien
,
Alimera
Amarin Gets Final Rejection on Key Drug Patent
TheStreet.com
Thu, 08/18/11 - 09:22 am
Tags:
patents
,
Amarin
,
AMR101
Amarin Gets 1 Step Closer to the Big Time
Motley Fool
Fri, 08/12/11 - 08:10 am
Tags:
Amarin
,
fish oil
,
AMR101
Amarin Reports Second Quarter 2011 Results
Yahoo
Wed, 08/10/11 - 10:51 am
Tags:
Amarin
,
earnings
The Race: FDA Approval or Buyout?
Motley Fool
Tue, 08/2/11 - 04:12 pm
Tags:
FDA
,
Amarin
,
AMR101
4-Star Stocks Poised to Pop: Amarin
Motley Fool
Mon, 07/25/11 - 10:51 am
Tags:
Amarin
Pages
« first
‹ previous
…
13
14
15
16
17
18
19
20
21
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.